Figure 2.
Decreased infiltration of CD3+, CD4+, and granzyme-B+ tumor-infiltrating lymphocytes (TILs) in SOX11+ compared with SOX11− nodal MCL primary cases. (A) Representative histological sections from SOX11+ and SOX11− nodal MCLs stained with specific anti-human CD20, cyclin D1, SOX11, CD3, CD4, CD8, and granzyme B (GZMB) antibodies (×40). Pictures contain insets with magnification (×200). (B) IHC quantifications of CD3+, CD4+, CD8+, and GZMB+ TILs and CD4+/CD8+ T-cell ratio in SOX11+ and SOX11− nodal MCLs. The significance of difference was determined by independent-samples Student t test: *P < .05, **P < .01. HPF, number of cells per high-power field (×400).

Decreased infiltration of CD3+, CD4+, and granzyme-B+ tumor-infiltrating lymphocytes (TILs) in SOX11+ compared with SOX11 nodal MCL primary cases. (A) Representative histological sections from SOX11+ and SOX11 nodal MCLs stained with specific anti-human CD20, cyclin D1, SOX11, CD3, CD4, CD8, and granzyme B (GZMB) antibodies (×40). Pictures contain insets with magnification (×200). (B) IHC quantifications of CD3+, CD4+, CD8+, and GZMB+ TILs and CD4+/CD8+ T-cell ratio in SOX11+ and SOX11 nodal MCLs. The significance of difference was determined by independent-samples Student t test: *P < .05, **P < .01. HPF, number of cells per high-power field (×400).

Close Modal

or Create an Account

Close Modal
Close Modal